Target intelligence / Profile preview

Heat shock protein family A member 1A (Hsp70) (Hsp70)

Target
Hsp70
Molecular classification
Molecular chaperone, Enzyme, ATPase
01

Overview

Heat shock protein 70 (Hsp70) is a highly conserved 70 kDa molecular chaperone that plays a central role in maintaining cellular protein homeostasis (proteostasis). It functions by assisting in the folding of nascent polypeptides, refolding misfolded proteins, and directing terminally damaged proteins toward degradation via the ubiquitin-proteasome system. In many cancers, Hsp70 is significantly overexpressed and can be translocated to the plasma membrane (mHsp70), where it contributes to tumor cell survival, metastasis, and resistance to chemotherapy and radiation. In neurodegenerative conditions, Hsp70 acts protectively by sequestering toxic protein aggregates, such as amyloid-beta and tau, to mitigate neuronal damage.\n\nInterestingly, membrane-bound Hsp70 also serves as a unique tumor-specific marker that can be recognized by the innate immune system, specifically natural killer (NK) cells, making it a target for novel immunotherapies. Pharmacological targeting of Hsp70 involves small molecule inhibitors of its ATPase domain, allosteric modulators, and monoclonal antibodies or peptides designed to engage the immune system against membrane-positive tumor cells. These strategies aim to disrupt the protective mechanisms of cancer cells or enhance the clearance of toxic aggregates in neurodegeneration.

Other names
HSPA1AHSP70-1HSP72DnaKHeat shock 70 kDa protein 1AInducible heat shock protein 70Heat shock protein family A member 1A
02

Mechanism of action

Inhibition of ATPase activity, allosteric modulation of the nucleotide-binding domain, disruption of protein-protein interactions with co-chaperones, inhibition of substrate binding, downregulation of protein expression, and activation of natural killer (NK) cells through membrane-bound epitopes.

03

Biological functions

Protein foldingApoptosisImmune responseCell proliferationCell survivalProtein degradationSignal transduction
04

Disease associations

CancerNeurodegenerative diseaseInflammationInfectionCardiovascular disease
05

Safety considerations

Off-target toxicity due to ubiquitous expressionCompensatory induction of other heat shock proteinsChallenges in achieving isoform-specific selectivityDual pro- and anti-inflammatory roles depending on localizationPotential for systemic toxicity in healthy tissues
06

Interacting drugs

VER-155008

9 more in the full profile.

07

Biomarkers

Serum Hsp70 levelMembrane-bound Hsp70 (mHsp70)Exosomal Hsp70Circulating tumor cells (CTCs) expressing Hsp70Hsp70 autoantibodies

Beyond the preview

Go deeper on Heat shock protein family A member 1A (Hsp70) (Hsp70).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock protein family A member 1A (Hsp70) (Hsp70).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call